Global Gastrointestinal OTC Drugs Market Insights and Forecast to 2026

Global Gastrointestinal OTC Drugs Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Gastrointestinal OTC Drugs Product Introduction
1.2 Market Segments
1.3 Key Gastrointestinal OTC Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Gastrointestinal OTC Drugs Market Size Growth Rate by Type
1.4.2 Laxatives
1.4.3 Anti-Flatulents
1.4.4 H2-Antaginists
1.4.5 Anti-Diarrheals
1.4.6 PPIs
1.4.7 Anti-Emetics
1.4.8 Other
1.5 Market by Application
1.5.1 Global Gastrointestinal OTC Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Gastrointestinal OTC Drugs Market Size, Estimates and Forecasts
2.1.1 Global Gastrointestinal OTC Drugs Revenue 2015-2026
2.1.2 Global Gastrointestinal OTC Drugs Sales 2015-2026
2.2 Global Gastrointestinal OTC Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Gastrointestinal OTC Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Gastrointestinal OTC Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Gastrointestinal OTC Drugs Competitor Landscape by Players
3.1 Gastrointestinal OTC Drugs Sales by Manufacturers
3.1.1 Gastrointestinal OTC Drugs Sales by Manufacturers (2015-2020)
3.1.2 Gastrointestinal OTC Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Gastrointestinal OTC Drugs Revenue by Manufacturers
3.2.1 Gastrointestinal OTC Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Gastrointestinal OTC Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Gastrointestinal OTC Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Gastrointestinal OTC Drugs Revenue in 2019
3.2.5 Global Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Gastrointestinal OTC Drugs Price by Manufacturers
3.4 Gastrointestinal OTC Drugs Manufacturing Base Distribution, Product Types
3.4.1 Gastrointestinal OTC Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gastrointestinal OTC Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Gastrointestinal OTC Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Gastrointestinal OTC Drugs Market Size by Type (2015-2020)
4.1.1 Global Gastrointestinal OTC Drugs Sales by Type (2015-2020)
4.1.2 Global Gastrointestinal OTC Drugs Revenue by Type (2015-2020)
4.1.3 Gastrointestinal OTC Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Gastrointestinal OTC Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Gastrointestinal OTC Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Gastrointestinal OTC Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Gastrointestinal OTC Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Gastrointestinal OTC Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Gastrointestinal OTC Drugs Market Size by Application (2015-2020)
5.1.1 Global Gastrointestinal OTC Drugs Sales by Application (2015-2020)
5.1.2 Global Gastrointestinal OTC Drugs Revenue by Application (2015-2020)
5.1.3 Gastrointestinal OTC Drugs Price by Application (2015-2020)
5.2 Gastrointestinal OTC Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Gastrointestinal OTC Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Gastrointestinal OTC Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Gastrointestinal OTC Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Gastrointestinal OTC Drugs by Country
6.1.1 North America Gastrointestinal OTC Drugs Sales by Country
6.1.2 North America Gastrointestinal OTC Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Gastrointestinal OTC Drugs Market Facts & Figures by Type
6.3 North America Gastrointestinal OTC Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Gastrointestinal OTC Drugs by Country
7.1.1 Europe Gastrointestinal OTC Drugs Sales by Country
7.1.2 Europe Gastrointestinal OTC Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Gastrointestinal OTC Drugs Market Facts & Figures by Type
7.3 Europe Gastrointestinal OTC Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Gastrointestinal OTC Drugs by Region
8.1.1 Asia Pacific Gastrointestinal OTC Drugs Sales by Region
8.1.2 Asia Pacific Gastrointestinal OTC Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Gastrointestinal OTC Drugs Market Facts & Figures by Type
8.3 Asia Pacific Gastrointestinal OTC Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Gastrointestinal OTC Drugs by Country
9.1.1 Latin America Gastrointestinal OTC Drugs Sales by Country
9.1.2 Latin America Gastrointestinal OTC Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Gastrointestinal OTC Drugs Market Facts & Figures by Type
9.3 Central & South America Gastrointestinal OTC Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Gastrointestinal OTC Drugs by Country
10.1.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Country
10.1.2 Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Gastrointestinal OTC Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Gastrointestinal OTC Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Gastrointestinal OTC Drugs Products Offered
11.1.5 GlaxoSmithKline Related Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Description and Business Overview
11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Gastrointestinal OTC Drugs Products Offered
11.2.5 Pfizer Related Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Description and Business Overview
11.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Johnson & Johnson Gastrointestinal OTC Drugs Products Offered
11.3.5 Johnson & Johnson Related Developments
11.4 Bayer
11.4.1 Bayer Corporation Information
11.4.2 Bayer Description and Business Overview
11.4.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bayer Gastrointestinal OTC Drugs Products Offered
11.4.5 Bayer Related Developments
11.5 Procter & Gamble
11.5.1 Procter & Gamble Corporation Information
11.5.2 Procter & Gamble Description and Business Overview
11.5.3 Procter & Gamble Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Procter & Gamble Gastrointestinal OTC Drugs Products Offered
11.5.5 Procter & Gamble Related Developments
11.6 Perrigo
11.6.1 Perrigo Corporation Information
11.6.2 Perrigo Description and Business Overview
11.6.3 Perrigo Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Perrigo Gastrointestinal OTC Drugs Products Offered
11.6.5 Perrigo Related Developments
11.7 Abbott
11.7.1 Abbott Corporation Information
11.7.2 Abbott Description and Business Overview
11.7.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Abbott Gastrointestinal OTC Drugs Products Offered
11.7.5 Abbott Related Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Description and Business Overview
11.8.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sanofi Gastrointestinal OTC Drugs Products Offered
11.8.5 Sanofi Related Developments
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Corporation Information
11.9.2 Teva Pharmaceutical Description and Business Overview
11.9.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Products Offered
11.9.5 Teva Pharmaceutical Related Developments
11.10 Nestle
11.10.1 Nestle Corporation Information
11.10.2 Nestle Description and Business Overview
11.10.3 Nestle Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Nestle Gastrointestinal OTC Drugs Products Offered
11.10.5 Nestle Related Developments
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Gastrointestinal OTC Drugs Products Offered
11.1.5 GlaxoSmithKline Related Developments
11.12 Reckitt Benckiser
11.12.1 Reckitt Benckiser Corporation Information
11.12.2 Reckitt Benckiser Description and Business Overview
11.12.3 Reckitt Benckiser Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Reckitt Benckiser Products Offered
11.12.5 Reckitt Benckiser Related Developments
11.13 Purdue Pharma
11.13.1 Purdue Pharma Corporation Information
11.13.2 Purdue Pharma Description and Business Overview
11.13.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Purdue Pharma Products Offered
11.13.5 Purdue Pharma Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Gastrointestinal OTC Drugs Market Estimates and Projections by Region
12.1.1 Global Gastrointestinal OTC Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Gastrointestinal OTC Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Gastrointestinal OTC Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Gastrointestinal OTC Drugs Sales Forecast (2021-2026)
12.2.2 North America: Gastrointestinal OTC Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Gastrointestinal OTC Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Gastrointestinal OTC Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Gastrointestinal OTC Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Gastrointestinal OTC Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Gastrointestinal OTC Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Gastrointestinal OTC Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Gastrointestinal OTC Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Gastrointestinal OTC Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Gastrointestinal OTC Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Gastrointestinal OTC Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Gastrointestinal OTC Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Gastrointestinal OTC Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Gastrointestinal OTC Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Gastrointestinal OTC Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Gastrointestinal OTC Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Gastrointestinal OTC Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Gastrointestinal OTC Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Gastrointestinal OTC Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Gastrointestinal OTC Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Gastrointestinal OTC Drugs Market Segments
Table 2. Ranking of Global Top Gastrointestinal OTC Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Gastrointestinal OTC Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Laxatives
Table 5. Major Manufacturers of Anti-Flatulents
Table 6. Major Manufacturers of H2-Antaginists
Table 7. Major Manufacturers of Anti-Diarrheals
Table 8. Major Manufacturers of PPIs
Table 9. Major Manufacturers of Anti-Emetics
Table 10. Major Manufacturers of Other
Table 11. Global Gastrointestinal OTC Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 12. Global Gastrointestinal OTC Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 13. Global Gastrointestinal OTC Drugs Sales by Regions 2015-2020 (K Pcs)
Table 14. Global Gastrointestinal OTC Drugs Sales Market Share by Regions (2015-2020)
Table 15. Global Gastrointestinal OTC Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Gastrointestinal OTC Drugs Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Gastrointestinal OTC Drugs Sales Share by Manufacturers (2015-2020)
Table 18. Global Gastrointestinal OTC Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Gastrointestinal OTC Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal OTC Drugs as of 2019)
Table 20. Gastrointestinal OTC Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Gastrointestinal OTC Drugs Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Gastrointestinal OTC Drugs Price (2015-2020) (USD/Pcs)
Table 23. Gastrointestinal OTC Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Gastrointestinal OTC Drugs Product Type
Table 25. Date of International Manufacturers Enter into Gastrointestinal OTC Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Gastrointestinal OTC Drugs Sales by Type (2015-2020) (K Pcs)
Table 28. Global Gastrointestinal OTC Drugs Sales Share by Type (2015-2020)
Table 29. Global Gastrointestinal OTC Drugs Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Gastrointestinal OTC Drugs Revenue Share by Type (2015-2020)
Table 31. Gastrointestinal OTC Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Gastrointestinal OTC Drugs Sales by Application (2015-2020) (K Pcs)
Table 33. Global Gastrointestinal OTC Drugs Sales Share by Application (2015-2020)
Table 34. North America Gastrointestinal OTC Drugs Sales by Country (2015-2020) (K Pcs)
Table 35. North America Gastrointestinal OTC Drugs Sales Market Share by Country (2015-2020)
Table 36. North America Gastrointestinal OTC Drugs Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Gastrointestinal OTC Drugs Revenue Market Share by Country (2015-2020)
Table 38. North America Gastrointestinal OTC Drugs Sales by Type (2015-2020) (K Pcs)
Table 39. North America Gastrointestinal OTC Drugs Sales Market Share by Type (2015-2020)
Table 40. North America Gastrointestinal OTC Drugs Sales by Application (2015-2020) (K Pcs)
Table 41. North America Gastrointestinal OTC Drugs Sales Market Share by Application (2015-2020)
Table 42. Europe Gastrointestinal OTC Drugs Sales by Country (2015-2020) (K Pcs)
Table 43. Europe Gastrointestinal OTC Drugs Sales Market Share by Country (2015-2020)
Table 44. Europe Gastrointestinal OTC Drugs Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Gastrointestinal OTC Drugs Revenue Market Share by Country (2015-2020)
Table 46. Europe Gastrointestinal OTC Drugs Sales by Type (2015-2020) (K Pcs)
Table 47. Europe Gastrointestinal OTC Drugs Sales Market Share by Type (2015-2020)
Table 48. Europe Gastrointestinal OTC Drugs Sales by Application (2015-2020) (K Pcs)
Table 49. Europe Gastrointestinal OTC Drugs Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Gastrointestinal OTC Drugs Sales by Region (2015-2020) (K Pcs)
Table 51. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Gastrointestinal OTC Drugs Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Gastrointestinal OTC Drugs Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Gastrointestinal OTC Drugs Sales by Type (2015-2020) (K Pcs)
Table 55. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Gastrointestinal OTC Drugs Sales by Application (2015-2020) (K Pcs)
Table 57. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Application (2015-2020)
Table 58. Latin America Gastrointestinal OTC Drugs Sales by Country (2015-2020) (K Pcs)
Table 59. Latin America Gastrointestinal OTC Drugs Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Gastrointestinal OTC Drugs Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Gastrointestinal OTC Drugs Revenue Market Share by Country (2015-2020)
Table 62. Latin America Gastrointestinal OTC Drugs Sales by Type (2015-2020) (K Pcs)
Table 63. Latin America Gastrointestinal OTC Drugs Sales Market Share by Type (2015-2020)
Table 64. Latin America Gastrointestinal OTC Drugs Sales by Application (2015-2020) (K Pcs)
Table 65. Latin America Gastrointestinal OTC Drugs Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2015-2020) (K Pcs)
Table 67. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Gastrointestinal OTC Drugs Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Gastrointestinal OTC Drugs Sales by Type (2015-2020) (K Pcs)
Table 71. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Gastrointestinal OTC Drugs Sales by Application (2015-2020) (K Pcs)
Table 73. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Application (2015-2020)
Table 74. GlaxoSmithKline Corporation Information
Table 75. GlaxoSmithKline Description and Major Businesses
Table 76. GlaxoSmithKline Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. GlaxoSmithKline Product
Table 78. GlaxoSmithKline Recent Development
Table 79. Pfizer Corporation Information
Table 80. Pfizer Description and Major Businesses
Table 81. Pfizer Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. Pfizer Product
Table 83. Pfizer Recent Development
Table 84. Johnson & Johnson Corporation Information
Table 85. Johnson & Johnson Description and Major Businesses
Table 86. Johnson & Johnson Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. Johnson & Johnson Product
Table 88. Johnson & Johnson Recent Development
Table 89. Bayer Corporation Information
Table 90. Bayer Description and Major Businesses
Table 91. Bayer Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Bayer Product
Table 93. Bayer Recent Development
Table 94. Procter & Gamble Corporation Information
Table 95. Procter & Gamble Description and Major Businesses
Table 96. Procter & Gamble Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. Procter & Gamble Product
Table 98. Procter & Gamble Recent Development
Table 99. Perrigo Corporation Information
Table 100. Perrigo Description and Major Businesses
Table 101. Perrigo Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. Perrigo Product
Table 103. Perrigo Recent Development
Table 104. Abbott Corporation Information
Table 105. Abbott Description and Major Businesses
Table 106. Abbott Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 107. Abbott Product
Table 108. Abbott Recent Development
Table 109. Sanofi Corporation Information
Table 110. Sanofi Description and Major Businesses
Table 111. Sanofi Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Sanofi Product
Table 113. Sanofi Recent Development
Table 114. Teva Pharmaceutical Corporation Information
Table 115. Teva Pharmaceutical Description and Major Businesses
Table 116. Teva Pharmaceutical Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Teva Pharmaceutical Product
Table 118. Teva Pharmaceutical Recent Development
Table 119. Nestle Corporation Information
Table 120. Nestle Description and Major Businesses
Table 121. Nestle Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 122. Nestle Product
Table 123. Nestle Recent Development
Table 124. Boehringer Ingelheim Corporation Information
Table 125. Boehringer Ingelheim Description and Major Businesses
Table 126. Boehringer Ingelheim Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 127. Boehringer Ingelheim Product
Table 128. Boehringer Ingelheim Recent Development
Table 129. Reckitt Benckiser Corporation Information
Table 130. Reckitt Benckiser Description and Major Businesses
Table 131. Reckitt Benckiser Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 132. Reckitt Benckiser Product
Table 133. Reckitt Benckiser Recent Development
Table 134. Purdue Pharma Corporation Information
Table 135. Purdue Pharma Description and Major Businesses
Table 136. Purdue Pharma Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 137. Purdue Pharma Product
Table 138. Purdue Pharma Recent Development
Table 139. Global Gastrointestinal OTC Drugs Sales Forecast by Regions (2021-2026) (K Pcs)
Table 140. Global Gastrointestinal OTC Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 141. Global Gastrointestinal OTC Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 142. Global Gastrointestinal OTC Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 143. North America: Gastrointestinal OTC Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 144. North America: Gastrointestinal OTC Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Europe: Gastrointestinal OTC Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 146. Europe: Gastrointestinal OTC Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Asia Pacific: Gastrointestinal OTC Drugs Sales Forecast by Region (2021-2026) (K Pcs)
Table 148. Asia Pacific: Gastrointestinal OTC Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 149. Latin America: Gastrointestinal OTC Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 150. Latin America: Gastrointestinal OTC Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 151. Middle East and Africa: Gastrointestinal OTC Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 152. Middle East and Africa: Gastrointestinal OTC Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 154. Key Challenges
Table 155. Market Risks
Table 156. Main Points Interviewed from Key Gastrointestinal OTC Drugs Players
Table 157. Gastrointestinal OTC Drugs Customers List
Table 158. Gastrointestinal OTC Drugs Distributors List
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastrointestinal OTC Drugs Product Picture
Figure 2. Global Gastrointestinal OTC Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Laxatives Product Picture
Figure 4. Anti-Flatulents Product Picture
Figure 5. H2-Antaginists Product Picture
Figure 6. Anti-Diarrheals Product Picture
Figure 7. PPIs Product Picture
Figure 8. Anti-Emetics Product Picture
Figure 9. Other Product Picture
Figure 10. Global Gastrointestinal OTC Drugs Sales Market Share by Application in 2020 & 2026
Figure 11. Hospital Pharmacies
Figure 12. Retail Pharmacies
Figure 13. Online Pharmacies
Figure 14. Gastrointestinal OTC Drugs Report Years Considered
Figure 15. Global Gastrointestinal OTC Drugs Market Size 2015-2026 (US$ Million)
Figure 16. Global Gastrointestinal OTC Drugs Sales 2015-2026 (K Pcs)
Figure 17. Global Gastrointestinal OTC Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2015-2020)
Figure 19. Global Gastrointestinal OTC Drugs Sales Market Share by Region in 2019
Figure 20. Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2015-2020)
Figure 21. Global Gastrointestinal OTC Drugs Revenue Market Share by Region in 2019
Figure 22. Global Gastrointestinal OTC Drugs Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Gastrointestinal OTC Drugs Revenue in 2019
Figure 24. Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Gastrointestinal OTC Drugs Sales Market Share by Type (2015-2020)
Figure 26. Global Gastrointestinal OTC Drugs Sales Market Share by Type in 2019
Figure 27. Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2015-2020)
Figure 28. Global Gastrointestinal OTC Drugs Revenue Market Share by Type in 2019
Figure 29. Global Gastrointestinal OTC Drugs Market Share by Price Range (2015-2020)
Figure 30. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2015-2020)
Figure 31. Global Gastrointestinal OTC Drugs Sales Market Share by Application in 2019
Figure 32. Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2015-2020)
Figure 33. Global Gastrointestinal OTC Drugs Revenue Market Share by Application in 2019
Figure 34. North America Gastrointestinal OTC Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Gastrointestinal OTC Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Gastrointestinal OTC Drugs Sales Market Share by Country in 2019
Figure 37. North America Gastrointestinal OTC Drugs Revenue Market Share by Country in 2019
Figure 38. U.S. Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Gastrointestinal OTC Drugs Market Share by Type in 2019
Figure 43. North America Gastrointestinal OTC Drugs Market Share by Application in 2019
Figure 44. Europe Gastrointestinal OTC Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Gastrointestinal OTC Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Gastrointestinal OTC Drugs Sales Market Share by Country in 2019
Figure 47. Europe Gastrointestinal OTC Drugs Revenue Market Share by Country in 2019
Figure 48. Germany Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Gastrointestinal OTC Drugs Market Share by Type in 2019
Figure 59. Europe Gastrointestinal OTC Drugs Market Share by Application in 2019
Figure 60. Asia Pacific Gastrointestinal OTC Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Gastrointestinal OTC Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Region in 2019
Figure 63. Asia Pacific Gastrointestinal OTC Drugs Revenue Market Share by Region in 2019
Figure 64. China Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Gastrointe

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110

According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......

Global Lansoprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102

The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......

Global Esomeprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89

The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126

Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......

Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......

Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......

Global Lansoprazole Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136

Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......

Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113

Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs